{"id":"tp-60699","type":"article-newspaper","title":"Recursion Aligns With FDA on Late-Stage Trial Design for REC-4881","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/60699","datePublished":"2026-11-18T17:50:46.000Z","dateModified":"2026-11-18T17:50:46.000Z","language":"en","abstract":"Recursion described the program as an early example of AI-assisted drug discovery pursuing a design intended to support registration.","section":"Business","references":[]}